ORGANIZATION AND BASIS OF PRESENTATION - Additional Information (Details) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended		12 Months Ended
	Aug. 31, 2018	Aug. 01, 2018	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018	Feb. 01, 2019	Jan. 01, 2019
Organization Consolidation And Presentation Of Financial Statements Line Items [Line Items]
Stock Issued During Period, Shares, New Issues	1,000,000
Shares Issued, Price Per Share	$ 6.25
Proceeds from Issuance of Common Stock	$ 5,609,215
Payments of Stock Issuance Costs	$ 640,785
Stockholders' Equity Note, Stock Split		1 share for every 25 shares
Common Stock, Shares Authorized		50,000,000	50,000,000		50,000,000		50,000,000
Conversion of Stock, Shares Converted		186,994,384
Conversion of Stock, Shares Issued		7,479,775
Deferred Revenue, Current			$ 2,944,630		$ 2,944,630		$ 2,626,712
Deferred Revenue, Noncurrent			232,021		232,021		402,075
Operating Lease Liability			952,864		952,864				$ 568,268
Operating Lease, Right-of-Use Asset			$ 942,588		$ 942,588		$ 0		$ 557,212
GA
Organization Consolidation And Presentation Of Financial Statements Line Items [Line Items]
Operating Lease, Right-of-Use Asset								$ 483,565
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Organization Consolidation And Presentation Of Financial Statements Line Items [Line Items]
Concentration Risk, Percentage			10.00%	9.00%	11.00%	11.00%
Accounts Receivable [Member] | Major Customer Number Two [Member]
Organization Consolidation And Presentation Of Financial Statements Line Items [Line Items]
Concentration Risk, Percentage							22.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Organization Consolidation And Presentation Of Financial Statements Line Items [Line Items]
Concentration Risk, Percentage					25.00%
Previously Reported [Member]
Organization Consolidation And Presentation Of Financial Statements Line Items [Line Items]
Common Stock, Shares Authorized		250,000,000